loading page

Genomic and immune microenvironment profiling in a case of metastatic intrathyroid thymic carcinoma
  • +8
  • Hiroki Ishii,
  • Takahiro Tsujikawa,
  • Naoki Oishi,
  • Arisa Kinouchi,
  • Kaname Sakamoto,
  • Junichi Mitsuda,
  • Hiroshi Ogi,
  • Kyoko Itoh,
  • Tetsuo Kondo,
  • Shigeru Hirano,
  • Daiju Sakurai
Hiroki Ishii
University of Yamanashi

Corresponding Author:[email protected]

Author Profile
Takahiro Tsujikawa
Kyoto Prefectural University of Medicine
Author Profile
Naoki Oishi
University of Yamanashi
Author Profile
Arisa Kinouchi
University of Yamanashi
Author Profile
Kaname Sakamoto
University of Yamanashi
Author Profile
Junichi Mitsuda
Kyoto Prefectural University of Medicine
Author Profile
Hiroshi Ogi
Kyoto Prefectural University of Medicine
Author Profile
Kyoko Itoh
Kyoto Prefectural University of Medicine
Author Profile
Tetsuo Kondo
University of Yamanashi
Author Profile
Shigeru Hirano
Kyoto Prefectural University of Medicine
Author Profile
Daiju Sakurai
University of Yamanashi
Author Profile

Abstract

Metastatic intrathyroid thymic carcinoma (ITTC) is a rare cancer that has no effective drugs. Herein, we report that comprehensive cancer mutation analysis revealed amplification of CD274 gene encoding PD-L1. Multiplex immunohistochemistry also clarified the presence of an immunosuppressive microenvironment via a PD-1/PD-L1 pathway in metastatic ITTC.
20 Mar 2022Submitted to Clinical Case Reports
22 Mar 2022Submission Checks Completed
22 Mar 2022Assigned to Editor
10 Apr 2022Reviewer(s) Assigned
07 May 2022Review(s) Completed, Editorial Evaluation Pending
10 May 2022Editorial Decision: Revise Minor
18 May 20221st Revision Received
20 May 2022Submission Checks Completed
20 May 2022Assigned to Editor
20 May 2022Review(s) Completed, Editorial Evaluation Pending
23 May 2022Editorial Decision: Accept
Jul 2022Published in Clinical Case Reports volume 10 issue 7. 10.1002/ccr3.6050